Last Updated: June 25, 2026

Drug Price Trends for HEMICLOR

✉ Email this page to a colleague

Average Pharmacy Cost for HEMICLOR

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Subscribe to access the full database, or Start Trial
Drug Name	NDC	Price/Unit ($)	Unit	Date
HEMICLOR 12.5 MG TABLET	50742-0285-30	0.95729	EACH	2026-06-17
HEMICLOR 12.5 MG TABLET	50742-0285-90	0.95729	EACH	2026-06-17
HEMICLOR 12.5 MG TABLET	50742-0285-30	0.95725	EACH	2026-05-20
HEMICLOR 12.5 MG TABLET	50742-0285-90	0.95725	EACH	2026-05-20
HEMICLOR 12.5 MG TABLET	50742-0285-90	0.95715	EACH	2026-04-22
HEMICLOR 12.5 MG TABLET	50742-0285-30	0.95715	EACH	2026-04-22
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

HEMICLOR Market Analysis and Price Projections: Revenue Outlook, Competitive Set, and Exclusivity-Driven Generic Risk

Last updated: June 2, 2026

HEMICLOR market sizing and pricing projections depend on identifying the marketed active ingredient, FDA approval pathway, dosage forms, and confirmed Orange Book listings. No complete, sourceable market and IP dataset is available in the provided context for “HEMICLOR,” so a complete and accurate forecast cannot be produced.

Key Takeaways

No complete market analysis or price projections for HEMICLOR can be generated without a verifiable mapping to the drug’s active ingredient, FDA product(s), and patent/exclusivity records.

FAQs

What is HEMICLOR’s active ingredient and labeled dosage form?
What is HEMICLOR’s FDA approval status and NDC-level labeling?
Is HEMICLOR listed in the Orange Book, and what patents control it?
What Paragraph IV or biosimilar challenges exist for HEMICLOR?
What generic entry risks exist for HEMICLOR by geography and timeline?

More… ↓

⤷ Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.